FDA Inspection 1269778 — Novo Nordisk Pharmaceutical Industries LP
The FDA completed an inspection of Novo Nordisk Pharmaceutical Industries LP on Jun 13, 2025 in Clayton, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 13, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Clayton, NC (United States)